Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells

Leukemia

Volumn 14, Issue 6, 2000, Pages 1080-1096

  Blalock, W L ^a   Moye, P W ^a   Chang, F ^a   Pearce, M ^a   Steelman, L S ^a   McMahon, M ^b   McCubrey, J A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; BCL2; Cytokine dependency; MEK1

Indexed keywords

CHIMERIC PROTEIN; COMPLEMENTARY DNA; CYTOKINE; ESTRADIOL; ESTROGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN BCL 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC CODE; HEMATOPOIETIC CELL; HORMONE BINDING; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RETROVIRUS; VIRUS INFECTION;

EID: 0034123442     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401793     Document Type: Article

References (74)

1. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA. Signal transduction, cell cycle regulatory, and anti-apoptotk pathways regulated by IL-3 in hematopoietic cells, possible sites for intervention with anti-neoplastic drugs. Leukemia 1999; 13: 1109-1166.
2. Wang XY, McCubrey JA. Regulation of interleukin-3 expression in normal and autocrine transformed hematopoietic cells. Int Oncol 1997; 10: 989-1001.
3. Wang XY, Steelman LS, McCubrey JA. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations which result in autocrine growth stimulation and malignant transformation. Cytokines Cell Mol Ther 1997; 3: 3-19.
4. McCubrey JA, Holland G, McKearn J, Risser R. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res 1989; 4: 97-109.
5. McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M. Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates IL-3-dependency of murine factor dependent cells by a ligand-dependent mechanism. Blood 1991; 78: 921-929.
6. McCubrey JA, Smith SR, Algate PA, de Vente JE, White MK, Steelman LS. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene 1993; 8: 2905-2915.
7. Mayo MW, Wang X-Y, Algate PA, Arana GF, Hoyle PE, Steelman LS, McCubrey JA. Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleu-kin-3-dependent hematopoietic cells. Blood 1995; 86: 3139-3150.
8. Wang X-Y, McCubrey JA. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and post-transcriptional mechanisms. Cell Growth Differ 1996; 7: 487-500.
9. Wang XY, McCubrey JA. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation. Leukemia 1997; 11: 1711-1725.
10. Thacker JD, Hogge DE. Cytokine-dependent engraftment of human myeloid leukemic cell lines in immunosuppressed mice. Leukemia 1994; 8: 871-877.
11. Cabert JA, Lopez M, Bangs CD, Martina N, Donlon TA, Mannoni P, Lee F. Characterization of spontaneous factor-independent cell lines derived from the human leukemia cell line TF-1; a dominant event. Leukemia 1994; 8: 1359-1368.
12. Kitamura T, Tange T, TeRasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependency on GM-CSF, IL-3 or erythropoietin. J Cell Physiol 1989; 140: 323-334.
13. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D. Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med 1982; 152: 1036-1047.
14. McKearn JP, McCubrey JA, Fagg B. Enrichment of hematopoietic precursor cells and cloning of multipotential B lymphocyte precursors. Proc Natl Acad Sci USA 1985; 82: 7414-7418.
15. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K-L. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
16. Miyajima A, Mui AL-F, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82: 1960-1974.
17. Algate PA, Steelman LS, Mayo MW, Miyajima A, McCubrey JA. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. Blood 1994; 83: 2450-2468.
18. Sakamoto KM, Mignacca RC, Gasson JC. Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors. Receptors Channels 1994; 2: 175-181.
19. Wong A, Sakamoto KM. Granulocyte-macrophage colony-stimulating factor induces the transcriptional activation of egr-1 through a protein kinase A-independent signaling pathway. J Biol Chem 1995; 270: 30271-30273.
20. Kwon EM, Sakamoto KM. The molecular mechanism of action of granulocyte-macrophage/colony-stimulating factor. J Invest Med 1996; 44; 442-446.
21. Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, McCubrey JA. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia 1996; 10: 528-542.
22. Ihle IN, Witthuhn BA, Quell FW, Yamamoto K, Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immun 1995; 13: 369-399.
23. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 1993; 90: 8429-8433.
24. Pratt JC, Weiss M, Sieff CA, Shoelson SE, Burakoff SJ, Ravichandran KS. Evidence for a physical association between the Shc-PTB domain and the β, chain of the granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem 1996; 271: 12137-12140.
25. Anderson SM, Burton EA, Koch BL. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn and phosphatidylinositol 3-kinase. J Biol Chem 1997; 272: 739-745.
26. Kinoshita T, Shirouzu M, Kamiya A, Hashimoto K, Yokoyama S, Miyajima A. Raf/MAPK and rapamycin-sensitive pathway mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells. Oncogene 1997; 15: 619-627.
27. McCubrey JA, May WS, Duronio V, Mufson A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 2000; 14: 9-21.
28. Dent P, Reardon DB, Morrison DK, Sturgill TW. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Mol Cell Biol 1995; 15: 4125-4135.
29. Dent P, Jarvis WD, Birrer MJ, Fisher PB, Schmidt-Ullrich RK, Grant S. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemosensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenidty. Leukemia 1998; 12: 1843-1850.
30. Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Lamer AC. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol Cell Biol, 1997; 17: 3833-3840.
31. Lee HJ, Mignacca RC, Sakamoto KM. Transcriptional activation of egr-1 by granulocyte-macrophage colony-stimulating factor but not interleukin 3 requires phosphorylation of cAMP response element-binding protein (CREB) on serine 133. J Biol Chem 1995; 270: 15979-15983.
32. Sakamoto KM, Fraser JK, Lee HJ, Lehman E, Gasson JC. Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Mol Cell Biol 1994; 14: 5975-5985.
33. Perkins GR, Marshall CJ, Collins MK. The role of MAP kinase in interleukin-3 stimulation of proliferation. Blood 1996; 87: 3669-5675.
34. Davis RJ. Transcriptional regulation by MAP kinases. Mol Repro Devel 1995; 42: 459-467.
35. Huang W, Kessler DS, Erikson RL. Biochemical and biological analysis of MEK1 phosphorylation site mutants. Mol Biol Cell 1995; 15: 237-245.
36. Brunet A, Pages G, Pouyssegur J. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 1994; 9: 3379-3387.
37. Krebs EG, Sege R, Seger D, Reszka AA, Munar ES, Eldar-Finkelman H, Dobrowolska G, Jensen AM, Campbell JS, Fischer EH. Over-expression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T.3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII. J Biol Chem 1994; 269: 25699-25709.
38. Alessandrini A, Greulich H, Huang W, Erikson RL. MEK1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J Biol Chem 1996; 271: 31612-31618.
39. Blalock WL, Steelman LS, Pearce M, Franklin RA, McCarthy SA. Cherwinski H, McMahon M, McCubrey JA. A conditionally active form of MEK1 abrogates cytokine-dependency in human and mouse hematopoietic cells. Oncogene 2000; 19: 526-536.
40. Kinoshita T, Yokata T, Arai K, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J 1995; 14: 265-275.
41. McCubrey JA, Steelman LS, Wang X-Y, Algate PA, Hoyle PE, White C, Davidian EW, Prevost KD, Robbins P, Mylott D, White MK. Differential effects of viral and cellular oncogenes on the growth factor dependency of hematopoietic cells. Int J Oncol 1995; 7: 295-310.
42. McCubrey JA, Steelman LS, Wang XY, Davidian EW, Hoyle PE, White CR, Prevost KD, Algate PA, Robbins P, Mylott D, White MK. Autocrine growth factor secretion after transformation of human cytokine-dependent cells by viral and cellular oncogenes. Int J Oncol 1995; 7: 573-586.
43. McCubrey JA, Steelman LS, Hoyle PA, Blalock WL, Weinstein-Oppenheimer CR, Franklin RA, Cherwinski H, Bosch E, McMahon M. Differential abilities of activated Rat oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1498; 12: 1903-1929.
44. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88: 386-401.
45. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 1997; 3: 614-620.
46. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Immunol 1990; 144: 3602-3610.
47. Sato N, Sakamaki K, Terada N, Arai K-I, Miyajima A. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J 1993; 12: 4181-1189.
48. 1 and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
49. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-xL. Cell 1996; 87: 619-628.
50. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687-689.
51. Ahmed NN, Grimes HE, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 anti-apoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 1997; 94: 3627-3632.
52. Scheid MP, Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci USA 1998; 95: 7459-7444.
53. Miller AD, Rosman CJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
54. Pritchard CA, Samuels ML, Bosch E, McMabon M. Conditionally oncogenic forms of the A-raf and B-raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 1995; 15: 6430-6442.
55. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
56. Samuels ML, Weber MJ, Bishop JM, McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 1993; 13: 6241-6252.
57. Bosch E, Cherwinski H, Peterson D, McMahon M. Mutations of critical amino acids affect the biological and biochemical propertics of oncogenic A-Raf and Raf-1. Oncogene 1997; 11: 1021-1034.
58. Dudley DT, Pung L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinases cascade. Proc Natl Acad Sci USA 1995; 92: 7686-7689.
59. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-27494.
60. McCubrey JA, Steelman LS, Sandlin G, Riddle RS, Ways DK. Effects of phorbol esters on an interleukin-3-dependent cell line. Blood 1990; 76: 63-72.
61. McCubrey JA, Steelman LS, McKearn JP. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3-dependent cell line. Oncogene Res 1991; 6: 1-12.
62. Ways DK, Qin W, Riddle RS, Garris TD, Bennett TE, Steelman LS, McCubrey JA. Differential effect of phorbol esters and IL-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell line. Blood 1991; 78: 2633-2641.
63. Mayo MW, Steelman LS, McCubrey JA. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-Jun expression. Oncogene 1994; 9: 1999-2008.
64. Fox MH. A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1980; 1: 71-77.
65. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996; 87: 629-638.
66. Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Lawrence Hovey I, Troppmair J, Rapp UR, Reed JC. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994; 9: 2751-2756.
67. Reed JC, Wang HG, Takayama S, Rapp UR. Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 1996; 93: 7063-7068.
68. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung VS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 1998; 18: 3504-3517.
69. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 1997; 272: 11671-11673.
70. Deng X, Ito T, Carr B, Mumby M, May WS. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J Biol Chem 1998; 273: 34157-34163.
71. Gp1. Mol Cell Biol 1997; 17: 5598-5611.
72. Ruvolo PP, Deng X, Carr BK, May WS. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998; 273: 25436-25442.
73. Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274: 20296-20300.
74. McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, Pierce M, White MK, Franklin R, Blalock WL. Effects of deregulated Raf and MEK1 expression on the cytokine-dependency of hematopoietic cells. Adv Enzyme Regl 2000 (in press).